1.
Rev Neurol
; 71(7): 275-276, 2020 10 01.
Article
in Spanish
| MEDLINE
| ID: mdl-32959360
ABSTRACT
TITLE: SARS-CoV-2, nuevo agente causal del síndrome de Guillain-Barré.
Subject(s)
Betacoronavirus/pathogenicity , Coronavirus Infections/complications , Guillain-Barre Syndrome/etiology , Pandemics , Pneumonia, Viral/complications , Antibodies, Viral/blood , Betacoronavirus/immunology , Betacoronavirus/isolation & purification , COVID-19 , COVID-19 Testing , Causality , Clinical Laboratory Techniques , Coronavirus Infections/diagnosis , Coronavirus Infections/epidemiology , Female , Guillain-Barre Syndrome/diagnosis , Guillain-Barre Syndrome/virology , Humans , Immunoglobulin G/blood , Immunoglobulin M/blood , Middle Aged , Neural Conduction , Oropharynx/virology , Pneumonia, Viral/epidemiology , Real-Time Polymerase Chain Reaction , SARS-CoV-2
2.
[Treatment with valproate and hepatic steatosis]. / Tratamiento con valproato y esteatosis hepática.
Rev Neurol
; 41(12): 766-7, 2005.
Article
in Spanish
| MEDLINE
| ID: mdl-16355364
3.
Rev. neurol. (Ed. impr.)
; 41(12): 766-767, 16 dic., 2005.
Article
in Es
| IBECS
| ID: ibc-043209
ABSTRACT
No disponible
No disponible
Subject(s)
Male , Adult , Humans , Anticonvulsants/adverse effects , Anticonvulsants/therapeutic use , Epilepsy/drug therapy , Fatty Liver/chemically induced , Valproic Acid/adverse effects , Valproic Acid/therapeutic use , Fatty Liver/diagnosis
4.
Rev Neurol
; 39(10): 998-9, 2004.
Article
in Spanish
| MEDLINE
| ID: mdl-15573326